Heidi R. Hope
- Cell Biology top 10%
-
- Melanoma and MAPK Pathways 4
- Metabolism, Diabetes, and Cancer 2
- Inflammasome and immune disorders 1
- Protein Kinase Regulation and GTPase Signaling 1
-
- NF-κB Signaling Pathways 2
-
- Synthesis and biological activity 3
-
- Cytokine Signaling Pathways and Interactions 3
-
- Computational Drug Discovery Methods 2
- Co-authors
- Linda J. PikeJoseph B. MonahanShaun R. SelnessJeffrey L. HirschDaniel T. ConnollyE. A. GulveDeborah M. HeuvelmanXiaoli Chen
- Journals
- The Journal of Experimental Medicine (1 paper)Biochemistry (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Heidi R. Hope
13 papers receiving 511 citations
Peers
Comparison fields: 5 of 73
- Cell Biology 151
- Molecular Biology 366
- Immunology 108
- Physiology 94
- Cancer Research 45
Countries citing papers authored by Heidi R. Hope
This map shows the geographic impact of Heidi R. Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi R. Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi R. Hope more than expected).
Fields of papers citing papers by Heidi R. Hope
This network shows the impact of papers produced by Heidi R. Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi R. Hope. The network helps show where Heidi R. Hope may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heidi R. Hope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 20 | |
| 4 | 2020 | 1 | |
| 5 | 2018 | 74 | |
| 6 | 2011 | 23 | |
| 7 | 2009 | 46 | |
| 8 | 2009 | 3 | |
| 9 | 2009 | 43 | |
| 10 | 2000 | 50 | |
| 11 | 2000 | 36 | |
| 12 | 2000 | 21 | |
| 13 | 1996 | 202 |
About Heidi R. Hope
Heidi R. Hope is a scholar working on Pharmacology, Oncology and Organic Chemistry, having authored 13 papers that have together received 528 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Synthesis and biological activity (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Computational Drug Discovery Methods (2 papers), Metabolism, Diabetes, and Cancer (2 papers), NF-κB Signaling Pathways (2 papers), Inflammasome and immune disorders (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). The work is most often cited by research in Cell Biology (151 citations), Molecular Biology (366 citations) and Immunology (108 citations). Heidi R. Hope has collaborated with scholars based in United States and China. Frequent co-authors include Linda J. Pike, Joseph B. Monahan, Shaun R. Selness, Jeffrey L. Hirsch, Daniel T. Connolly, E. A. Gulve, Deborah M. Heuvelman, Xiaoli Chen, Stuart A. Ross and Barry Burnette. Their work appears in journals such as The Journal of Experimental Medicine, Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.